Timothy J. Doyle

Timothy J. Doyle

Auto-generated profile, based on publicly available information

Timothy J. Doyle

Bureau of Epidemiology, Florida Department of Health , Tallahassee, Florida

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2002 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
TDTimothy J. Doyle
Timothy J. Doyle
MGM. Kathleen Glynn
M. Kathleen Glynn
SGSamuel L. Groseclose
Samuel L. Groseclose
Despite state and local laws requiring medical providers to report notifiable infectious diseases to public health authorities, reporting is believed to be incomplete. Through means of an analytical literature review, the authors synthesize current knowledge on the completeness of disease reporting and identify factors associated with reporting completeness. The review was limited to published studies, conducted in the United States between 1970 and 1999, that quantitatively assessed infectious disease reporting completeness. Thirty-three studies met the inclusion criteria. Reporting completeness, expressed between 0% and 100%, was treated as the dependent outcome variable in statistical analysis; disease, study location, time period, study design, and study size were treated as independent variables. Fifty-six distinct measures of reporting completeness were identified for 21 diseases. Reporting completeness varied from 9% to 99% and was most strongly associated with the disease being reported. The mean reporting completeness for acquired immunodeficiency syndrome, sexually transmitted diseases, and tuberculosis as a group was significantly higher (79%) than for all other diseases combined (49%) (p < 0.01).

15 July 1996 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
WZWei Zheng
Wei Zheng
TDTimothy J. Doyle
Timothy J. Doyle
LKLawrence H. Kushi
Lawrence H. Kushi
TSThomas A. Sellers
Thomas A. Sellers
CHChing-Ping Hong
Ching-Ping Hong
AFAaron R. Folsom
Aaron R. Folsom
Tea has consistently been shown to inhibit the occurrence of tumors in experimental animals. The evidence for such a beneficial effect in humans, however, is limited. The authors examined the association between non-herbal tea consumption and cancer incidence in a prospective cohort study of 35, 369 postmenopausal Iowa women. In this cohort, information on the frequency of tea drinking and other dietary and lifestyle factors was collected by mailed survey in 1986. After 8 years of follow-up, 2,936 incident non-skin cancer cases were ascertained in this cohort through the State Health Registry of Iowa. Proportional hazards regressions were used to derive adjusted relative risks and 95% confidence intervals for the association between tea consumption and cancer incidence. After controlling for confounding factors, the authors found that regular tea consumption was related to a slight, but not statistically significant, reduced incidence of all cancers combined. Inverse associations with increasing frequency of tea drinking were seen for cancers of the digestive tract (p for trend, 0.04) and the urinary tract (p for trend, 0.02). For women who reported drinking >2 cups (474 ml) of tea per day, compared with those who never or occasionally drank tea, the relative risk for digestive tract cancers was 0.68 (95% confidence interval (Cl) 0.47–0.98) and for urinary tract cancers, 0.40 (95% Cl 0.16–0.98). Similar inverse associations were seen for specific digestive and urinary tract cancers, although site-specific analyses were not statistically significant. No appreciable association of tea drinking was found with melanoma, non-Hodgkin's lymphoma, or cancers of the pancreas, lung, breast, uterine corpus, or ovary. This study suggests that tea, one of the most popular beverages consumed worldwide, may protect against some cancers in postmenopausal women. Am J Epidemiol 1996; 144: 175–82.

1 June 2000 in Emerging Infectious Diseases
Verified
Journal Article
Open access
GGGregory E. Glass
Gregory E. Glass
JCJames E. Cheek
James E. Cheek
JPJonathan A. Patz
Jonathan A. Patz
TSTimothy M. Shields
Timothy M. Shields
TDTimothy J. Doyle
Timothy J. Doyle
RBRalph Bryan
Ralph Bryan
Volume 6, Number 3—June 2000 - Emerging Infectious Disease journal - CDC

1 July 1997 in American Journal of Public Health
Verified
Journal Article
Closed access
TDT J Doyle
T J Doyle
WZW Zheng
W Zheng
JCJames Cerhan
James Cerhan
CHC P Hong
C P Hong
TST A Sellers
T A Sellers
AFA R Folsom
A R Folsom
OBJECTIVES: This study assessed the association of drinking water source and chlorination by-product exposure with cancer incidence. METHODS: A cohort of 28,237 Iowa women reported their drinking water source. Exposure to chlorination by-products was determined from statewide water quality data. RESULTS: In comparison with women who used municipal ground-water sources, women with municipal surface water sources were at an increased risk of colon cancer and all cancers combined. A clear dose-response relation was observed between four categories of increasing chloroform levels in finished drinking water and the risk of colon cancer and all cancers combined. The relative risks were 1.00, 1.06, 1.39, and 1.68 for colon cancer and 1.00, 1.04, 1.24, and 1.25 for total cancers. No consistent association with either water source or chloroform concentration was observed for other cancer sites. CONCLUSIONS: These results suggest that exposure to chlorination by-products in drinking water is associated with increased risk of colon cancer.

24 October 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TDTimothy J. Doyle
Timothy J. Doyle
KGKate Goodin
Kate Goodin
JHJanet J. Hamilton
Janet J. Hamilton
Pregnant women have been identified as a high risk group for severe illness with 2009 pandemic influenza A(H1N1) virus infection (pH1N1). Obesity has also been identified as a risk factor for severe illness, though this has not been thoroughly assessed among pregnant women. The objectives of this study were to provide risk estimates for adverse maternal and neonatal outcomes associated with pH1N1 illness during pregnancy and to assess the role of obesity in these outcomes. We established a retrospective population-based cohort of all live births occurring in Florida during the first 15 months of the pandemic. Illness with pH1N1 during pregnancy was ascertained through record linkage with the Florida state notifiable disease surveillance database. Data from the birth record, including pre-pregnancy body mass index, were analyzed to assess risk of adverse outcomes associated with pH1N1 illness. A total of 194 women were identified through surveillance with pH1N1 illness during pregnancy. Children born to women with pH1N1 illness during pregnancy were at increased risk for low birth weight [OR (95%CI): 1.78 (1.11-2.860)], premature birth [2.21 (1.47-3.330)], and infant death [4.46 (1.80-11.00)], after adjusting for other factors. Women with pH1N1 illness during pregnancy were at increased risk for severe outcomes including admission to an intensive care unit. Obesity was an observed risk factor, both for the more severe pH1N1 illness detected through surveillance, and for severe maternal outcomes. Case-patients in this analysis likely represent the most severely ill subset of all women infected with pH1N1 during pregnancy, limiting the generalizability of these findings to more severely ill patients rather than influenza infection in general. Nevertheless, these results suggest that more severe pH1N1 illness during pregnancy is associated with adverse neonatal outcomes and that pregnant women should continue to be targeted for appropriate prophylaxis and early treatment.

26 March 2021 in MMWR. Morbidity and Mortality Weekly Report
Verified
Journal Article
Closed access
TDTimothy Doyle
Timothy Doyle
KKKatherine Kendrick
Katherine Kendrick
TTThomas Troelstrup
Thomas Troelstrup
MGMegan Gumke
Megan Gumke
JEJerri Edwards
Jerri Edwards
CBCarina Blackmore
Carina Blackmore
COVID-19 school-related cases among Florida students correlated with community incidence in the counties observed, and was highest in smaller counties, districts without mask requirements, and those that reopened earliest.